Group One Trading’s Roivant Sciences ROIV Stock Holding History

Group One Trading’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Buy	+39,272	New	+$1.01M	﹤0.01%	2628
2025 Q3	–	Sell	-37,316	Closed	-$462K	–	9044
2025 Q2	$421K	Buy	37,316 +36,101	+2,971%	+$391K	﹤0.01%	3591
2025 Q1	$12.3K	Buy	+1,215	New	+$13.1K	﹤0.01%	6123
2024 Q3	–	Sell	-44,604	Closed	-$508K	–	7265
2024 Q2	$471K	Sell	44,604 -5,064	-10%	-$55.5K	﹤0.01%	2612
2024 Q1	$524K	Buy	+49,668	New	+$536K	﹤0.01%	2683
2023 Q4	–	Sell	-71,687	Closed	-$699K	–	8081
2023 Q3	$837K	Buy	71,687 +53,413	+292%	+$604K	﹤0.01%	2436
2023 Q2	$184K	Buy	+18,274	New	+$163K	﹤0.01%	4021
2022 Q4	–	Sell	-11,100	Closed	-$61.7K	–	7973
2022 Q3	$36K	Buy	+11,100	New	+$43K	﹤0.01%	5664

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's ROIV Position: Q1 2026 in Review

Group One Trading opened a new position in Roivant Sciences (ROIV) in Q1 2026: 39,272 shares worth $1.09M. The stake represents ﹤0.01% of the portfolio and ranks #2628 among its holdings. This is a return to the name: Group One Trading previously reported a position in ROIV as recently as Q2 2025.

Group One Trading first reported a position in ROIV in Q3 2022 and has held it in 8 quarters since. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Group One Trading held 39,272 shares of Roivant Sciences worth $1.09M as of Q1 2026.
Roivant Sciences was a new Group One Trading position in Q1 2026.
Roivant Sciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2628 holding.
Group One Trading first reported a position in Roivant Sciences in Q3 2022 and has held it in 8 quarters since.
440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.